Literature DB >> 30028025

Paranoia and interpersonal functioning across the continuum from healthy to pathological - Network analysis.

Michal Hajdúk1,2, Hans S Klein3, Philip D Harvey4,5, David L Penn6,7, Amy E Pinkham3,8.   

Abstract

OBJECTIVE: Previous research has suggested that paranoia is associated with impaired social functioning in patients with schizophrenia and healthy individuals with high levels of paranoid ideation. This study analysed the relationship between paranoia and interpersonal functioning across the paranoia continuum using network analysis.
METHOD: Levels of paranoid ideation and interpersonal functioning were measured in a non-clinical sample (N = 853) and in patients with schizophrenia spectrum disorders (N = 226). Network analyses were used to examine the nature of paranoia's relation to interpersonal functioning in both populations.
RESULTS: Although the most central characteristic of paranoia in both samples was the feeling of being talked about behind one's back, across samples, individual characteristics were differentially related to various aspects of interpersonal functioning. Among clinical individuals, difficulties in interpersonal functioning were related to perceived previous experiences of being treated poorly by others, whereas among the non-clinical sample, interpersonal functioning was related to negative beliefs about others.
CONCLUSIONS: The current results support previous findings linking paranoid ideation to interpersonal functioning in both clinical and non-clinical samples. Patterns of these relationships differed slightly across groups. Results in general support a continuum model of paranoia. PRACTITIONER POINTS: Network analyses were used to identify central aspects of persecutory ideation in both clinical and non-clinical samples. Qualitative assessment of clinical and non-clinical networks revealed similar central symptoms and supported a continuum model of paranoia. Central aspects of paranoia, that is, feeling that others have talked about oneself behind one's back, being disappointed by others, and having distressing feelings of being watched by others, were associated with deficits in interpersonal functioning in both samples. Central aspects of paranoia may be beneficial targets for psychosocial interventions aimed at reducing paranoid ideation and improving interpersonal functioning. Demographic characteristics for this study differed between samples which may limit generalization of findings. Future research is needed to explore temporal associations and moment-to-moment dynamics between paranoid ideation and problems in interpersonal functioning.
© 2018 The British Psychological Society.

Entities:  

Keywords:  interpersonal functioning; network analysis; paranoia

Mesh:

Year:  2018        PMID: 30028025      PMCID: PMC6339834          DOI: 10.1111/bjc.12199

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  43 in total

1.  Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory).

Authors:  E R Peters; S A Joseph; P A Garety
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

2.  SLOF: a behavioral rating scale for assessing the mentally ill.

Authors:  L C Schneider; E L Struening
Journal:  Soc Work Res Abstr       Date:  1983

3.  Psychological investigation of the structure of paranoia in a non-clinical population.

Authors:  Daniel Freeman; Philippa A Garety; Paul E Bebbington; Benjamin Smith; Rebecca Rollinson; David Fowler; Elizabeth Kuipers; Katarzyna Ray; Graham Dunn
Journal:  Br J Psychiatry       Date:  2005-05       Impact factor: 9.319

4.  Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI).

Authors:  Emmanuelle Peters; Stephen Joseph; Samantha Day; Philippa Garety
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

5.  Social cognition and subclinical paranoid ideation.

Authors:  J A Martin; D L Penn
Journal:  Br J Clin Psychol       Date:  2001-09

6.  Emotional reactivity to daily life stress in psychosis.

Authors:  I Myin-Germeys; J van Os; J E Schwartz; A A Stone; P A Delespaul
Journal:  Arch Gen Psychiatry       Date:  2001-12

7.  Persecutory beliefs, attributions and theory of mind: comparison of patients with paranoid delusions, Asperger's syndrome and healthy controls.

Authors:  Jaime S Craig; Christopher Hatton; Fiona B Craig; Richard P Bentall
Journal:  Schizophr Res       Date:  2004-07-01       Impact factor: 4.939

8.  The role of subclinical paranoia on social perception and behavior.

Authors:  Dennis R Combs; David L Penn
Journal:  Schizophr Res       Date:  2004-07-01       Impact factor: 4.939

9.  Paranoia and self-consciousness.

Authors:  A Fenigstein; P A Vanable
Journal:  J Pers Soc Psychol       Date:  1992-01

10.  Psychotic symptoms in an urban general medicine practice.

Authors:  Mark Olfson; Roberto Lewis-Fernández; Myrna M Weissman; Adriana Feder; Marc J Gameroff; Daniel Pilowsky; Milton Fuentes
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

View more
  4 in total

1.  A preliminary investigation of paranoia variability and its association with social functioning.

Authors:  Linlin Fan; Emily Bass; Hans Klein; Cassi Springfield; Amy Pinkham
Journal:  Schizophr Res Cogn       Date:  2022-05-18

2.  Treatment decision-making needs among emerging adults with early psychosis.

Authors:  Elizabeth C Thomas; John Suarez; Alicia Lucksted; Laura Siminoff; Irene Hurford; Lisa Dixon; Maria O'Connell; Mark Salzer
Journal:  Early Interv Psychiatry       Date:  2021-02-17       Impact factor: 2.721

3.  The profile of unusual beliefs associated with metacognitive thinking and attributional styles.

Authors:  Elle P Coleman; Rodney J Croft; Emma Barkus
Journal:  Psych J       Date:  2022-02-15

4.  Associations of psychotic-like experiences, related symptoms, and working memory with functioning.

Authors:  Charlotte A Chun; Shanna Cooper; Lauren M Ellman
Journal:  Eur Psychiatry       Date:  2020-02-24       Impact factor: 5.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.